Error loading player: No playable sources found
Session VI – Going Beyond the mAb
Date
October 1, 2020
This product is not available for individual purchase, but it is available as part of the following products:
CE PHARM 2020: CE IN THE BIOTECHNOLOGY & PHARMACEUTICAL INDUSTRIES
Co-Chairs
Boehringer Ingelheim Pharma GmbH & Co. KG
Eli Lilly and Company
Related Products
A Holistic Strategy to Characterize the in-vivo Stability of Novel Modalities using Affinity Capture Coupled to LC-MS or CE-Based Methods
Antibody-derived novel modalities have become a significant portion of the early-stage R&D pipeline in
Innovative Capillary Electrophoresis Solutions for Gene Therapy Research and Development
A new class of therapeutics has emerged in recent years, in which the core genetic information of a diseased patient can be changed or replaced. This therapy, called gene therapy, harnesses not only leading-edge genetic manipulation tools (i.e…
